| 1 |
Lancet T. The Liver in Heart-failure [J]. Lancet, 1951, 258(6682): 530-531.
|
| 2 |
Kwon HM, Hwang GS. Cardiovascular dysfunction and liver transplantation [J]. Korean J Anesthesiol, 2018, 71(2): 85-91.
|
| 3 |
Ceolotto G, Papparella I, Sticca A, et al. An abnormal gene expression of the β-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats [J]. Hepatology, 2008, 48(6): 1913-1923.
|
| 4 |
Hu LS, George J, Wang JH. Current concepts on the role of nitric oxide in portal hypertension [J]. World J Gastroenterol, 2013, 19(11): 1707-1717.
|
| 5 |
Baldassarre M, Giannone FA, Napoli L, et al. The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives [J]. Liver Int, 2013, 33(9): 1298-1308.
|
| 6 |
Voiosu AM, Wiese S, Voiosu TA, et al. Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosis [J]. Eur J Gastroenterol Hepatol, 2018, 30(4): 392-397.
|
| 7 |
Yang YY, Liu H, Nam SW, et al. Mechanisms of TNFα-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFα and endocannabinoids [J]. J Hepatol, 2010, 53(2): 298-306.
|
| 8 |
雷旭, 殷华, 柏杏丽, 等. 气体信号分子硫化氢在肝硬化心肌病大鼠心肌组织中的变化 [J]. 世界华人消化杂志, 2015(35): 5606-5612.
|
| 9 |
Fouad YM, Yehia R. Hepato-cardiac disorders [J]. World J Hepatol, 2014, 6(1): 41-54.
|
| 10 |
Glenn TK, Honar H, Liu H, et al. Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats [J]. J Hepatol, 2011, 55(6): 1249-1255.
|
| 11 |
Ma Z, Lee SS, Meddings JB. Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy [J]. J Hepatol, 1997, 26(4): 904-912.
|
| 12 |
Nam SW, Liu H, Wong JZ, et al. Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice [J]. Clin Sci (Lond), 2014, 127(8): 519-526.
|
| 13 |
李小鹏, 余珊珊, 李路, 等. 肝硬化患者左心功能变化与终末期肝病模型评分的相关性研究 [J]. 南方医科大学学报, 2015(4): 557-561.
|
| 14 |
Barbosa M, Guardado J, Marinho C, et al. Cirrhotic cardiomyopathy: Isn′t stress evaluation always required for the diagnosis? [J]. World J Hepatol, 2016, 8(3): 200-206.
|
| 15 |
Sampaio F, Pimenta J, Bettencourt N, et al. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study [J]. Liver Int, 2013, 33(8): 1158-1165.
|
| 16 |
Altekin RE, Caglar B, Karakas MS, et al. Evaluation of subclinical left ventricular systolic dysfunction using two-dimensional speckle-tracking echocardiography in patients with non-alcoholic cirrhosis [J]. Hellenic J Cardiol, 2014, 55(5): 402-410.
|
| 17 |
Møller S, Wiese S, Halgreen H, et al. Diastolic dysfunction in cirrhosis [J]. Heart Fail Rev, 2016, 21(5): 599-610.
|
| 18 |
Merli M, Calicchia A, Ruffa A, et al. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease [J]. Eur J Intern Med, 2013, 24(2): 172-176.
|
| 19 |
Wood PW, Choy JB, Nanda NC, et al. Left ventricular ejection fraction and volumes: it depends on the imaging method [J]. Echocardiography, 2014, 31(1): 87-100.
|
| 20 |
常荷, 贾春梅, 徐琨, 等. 实时三维超声心动图定量评价肝硬化患者左心室收缩功能及同步性 [J/CD]. 中华医学超声杂志(电子版), 2016, 13(1): 39-44.
|
| 21 |
姜舒. 超声心动图评价肝硬化患者左心及右心功能[D]. 吉林大学, 2016.
|
| 22 |
Yotti R, Ripoll C, Benito Y, et al. Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis [J]. Hepatology, 2017, 65(6): 2019-2030.
|
| 23 |
Rimbas RC, Baldea SM, Guerra RDGA, et al. New Definition Criteria of Myocardial Dysfunction in Patients with Liver Cirrhosis: a Speckle Tracking and Tissue Doppler Imaging Study [J]. Ultrasound Med Biol, 2018, 44(3): 562-574.
|
| 24 |
Kadappu KK, Thomas L. Tissue Doppler imaging in echocardiography: value and limitations [J]. Heart Lung Circ, 2015, 24(3): 224-233.
|
| 25 |
Pagourelias ED, Sotiriou P, Papadopoulos CE, et al. Left Ventricular Myocardial Mechanics in Cirrhosis: a Speckle Tracking Echocardiographic Study [J]. Echocardiography, 2016, 33(2): 223-232.
|
| 26 |
Seo Y, Ishizu T, Atsumi A, et al. Three-dimensional speckle tracking echocardiography [J]. Circ J, 2014, 78(6): 1290-1301.
|
| 27 |
余珊珊, 孙露, 韩东刚, 等. 超声三维斑点追踪技术检查肝硬化患者左心室收缩功能初步研究 [J]. 实用肝脏病杂志, 2018, 21(2): 245-248.
|
| 28 |
Smiseth OA, Torp H, Opdahl A, et al. Myocardial strain imaging: how useful is it in clinical decision making? [J]. Eur Heart J, 2016, 37(15): 1196-1207.
|
| 29 |
Kim MY, Baik SK, Won CS, et al. Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis [J]. Korean J Hepatol, 2010, 16(4): 376-382.
|
| 30 |
Sanford KL, Williams KM, Archbald JA, et al. Non-physician-led exercise stress testing is a safe and effective practice [J]. Crit Pathw Cardiol, 2013, 12(4): 177-180.
|
| 31 |
苗俊旺, 尹立雪. 速度向量成像联合等长负荷试验评价肝硬化右心室收缩期心肌力学功能 [J]. 中华超声影像学杂志, 2014, 23(8): 656-661.
|
| 32 |
张京红, 卢振. 肝硬化患者实时三维超声心动图和多普勒组织成像对左心室舒张功能的研究 [J]. 中国医刊, 2013, 48(7): 89-90.
|
| 33 |
Salari A, Shafaghi A, Ofoghi M, et al. Diastolic dysfunction and severity of cirrhosis in nonalcoholic cirrhotic patients [J]. Int J Hepatol, 2013, 2013: 892876.
|
| 34 |
Somani PO, Contractor Q, Chaurasia AS, et al. Diastolic dysfunction characterizes cirrhotic cardiomyopathy [J]. Indian Heart J, 2014, 66(6): 649-655.
|
| 35 |
Falletta C, Filì D, Nugara C, et al. Diastolic dysfunction diagnosed by tissue Doppler imaging in cirrhotic patients: Prevalence and its possible relationship with clinical outcome [J]. Eur J Intern Med, 2015, 26(10): 830-834.
|
| 36 |
Amoozgar H, Ermis R, Honar N, et al. Myocardial Performance after Successful Liver Transplantation [J]. Int J Organ Transplant Med, 2016, 7(2): 77-83.
|
| 37 |
Silvestre OM, Bacal F, de Souza Ramos D, et al. Impact of the severity of end-stage liver disease in cardiac structure and function [J]. Ann Hepatol, 2013, 12(1): 85-91.
|
| 38 |
Merli M, Torromeo C, Giusto M, et al. Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass [J]. Liver Int, 2017, 37(5): 700-706.
|
| 39 |
向覃言秋, 孙阳, 王志刚, 等. 实时三维超声及斑点追踪技术评价非酒精性肝硬化患者左心房功能 [J]. 中国医学影像技术, 2018, 34(2): 232-236.
|
| 40 |
葛晓颖, 郑哲岚. 实时三维超声和二维斑点追踪技术评价肝硬化患者右心房功能 [J]. 中国超声医学杂志, 2016, 32(4): 307-309.
|